SLC5A2 and Nephropathy: The most important finding obtained as a result of this study: The risk of nephropathy due to the use of contrast media after CAG and/or PCI procedures in diabetic patients with SGLT2 inhibitor in the treatment regimen was found to be significantly lower than in the patient group who did not use SGLT2 inhibitors.